Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment.

Martin JD, Panagi M, Wang C, Khan TT, Martin MR, Voutouri C, Toh K, Papageorgis P, Mpekris F, Polydorou C, Ishii G, Takahashi S, Gotohda N, Suzuki T, Wilhelm ME, Melo VA, Quader S, Norimatsu J, Lanning RM, Kojima M, Stuber MD, Stylianopoulos T, Kataoka K, Cabral H.

ACS Nano. 2019 Jun 12. doi: 10.1021/acsnano.8b07865. [Epub ahead of print]

PMID:
31187975
2.

Growth patterns of small peripheral squamous cell carcinoma of the lung and their impacts on pathological and biological characteristics of tumor cells.

Omori T, Aokage K, Nakamura H, Katsumata S, Miyoshi T, Sugano M, Kojima M, Fujii S, Kuwata T, Ochiai A, Ikeda N, Tsuboi M, Ishii G.

J Cancer Res Clin Oncol. 2019 Jul;145(7):1773-1783. doi: 10.1007/s00432-019-02937-9. Epub 2019 May 21.

PMID:
31115670
3.

Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.

Maeda M, Takeshima H, Iida N, Hattori N, Yamashita S, Moro H, Yasukawa Y, Nishiyama K, Hashimoto T, Sekine S, Ishii G, Ochiai A, Fukagawa T, Katai H, Sakai Y, Ushijima T.

Gut. 2019 May 13. pii: gutjnl-2018-317645. doi: 10.1136/gutjnl-2018-317645. [Epub ahead of print]

PMID:
31085554
4.

Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC.

Katsumata S, Aokage K, Ishii G, Nakasone S, Sakai T, Okada S, Miyoshi T, Tane K, Tsuboi M.

J Thorac Oncol. 2019 May 2. pii: S1556-0864(19)30313-2. doi: 10.1016/j.jtho.2019.04.016. [Epub ahead of print]

PMID:
31055075
5.

Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case report.

Naito T, Umemura S, Nakamura H, Zenke Y, Udagawa H, Kirita K, Matsumoto S, Yoh K, Niho S, Motoi N, Aokage K, Tsuboi M, Ishii G, Goto K.

Thorac Cancer. 2019 May;10(5):1285-1288. doi: 10.1111/1759-7714.13070. Epub 2019 Apr 10.

6.

Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.

Miyoshi T, Aokage K, Katsumata S, Tane K, Ishii G, Tsuboi M.

Ann Thorac Surg. 2019 Jul;108(1):249-255. doi: 10.1016/j.athoracsur.2019.01.079. Epub 2019 Mar 12.

PMID:
30876742
7.

The association analysis between HLA-A*26 and Behçet's disease.

Nakamura J, Meguro A, Ishii G, Mihara T, Takeuchi M, Mizuki Y, Yuda K, Yamane T, Kawagoe T, Ota M, Mizuki N.

Sci Rep. 2019 Mar 14;9(1):4426. doi: 10.1038/s41598-019-40824-y.

8.

Stapling cartridge lavage cytology in limited resection for pulmonary malignant tumors: assessment of cytological status of the surgical margin.

Miyoshi T, Yoshida J, Aokage K, Tane K, Ishii G, Tsuboi M.

Heliyon. 2019 Feb 15;5(2):e01240. doi: 10.1016/j.heliyon.2019.e01240. eCollection 2019 Feb.

9.

Clinicopathological characteristics associated with necrosis in pulmonary metastases from colorectal cancer.

Suzuki J, Kojima M, Aokage K, Sakai T, Nakamura H, Ohara Y, Tane K, Miyoshi T, Sugano M, Fujii S, Kuwata T, Ochiai A, Ito M, Suzuki K, Tsuboi M, Ishii G.

Virchows Arch. 2019 May;474(5):569-575. doi: 10.1007/s00428-019-02535-7. Epub 2019 Feb 14.

PMID:
30762121
10.

Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP.

Kadota T, Seo S, Fuse H, Ishii G, Itoh K, Yano T, Kaneko K, Tsukasaki K.

Cancer Med. 2019 Mar;8(3):982-989. doi: 10.1002/cam4.1982. Epub 2019 Feb 7.

11.

Endoscopic submucosal resection using a ligation device without injection for duodenal neuroendocrine tumors.

Oono Y, Shinmura K, Hori K, Yoda Y, Ishii G, Ikematsu H, Yano T.

Surg Endosc. 2019 Jun;33(6):2008-2014. doi: 10.1007/s00464-018-06642-5. Epub 2019 Jan 2.

PMID:
30604268
12.

Radiologic Criteria in Predicting Pathologic Less Invasive Lung Cancer According to TNM 8th Edition.

Katsumata S, Aokage K, Nakasone S, Sakai T, Okada S, Miyoshi T, Tane K, Hayashi R, Ishii G, Tsuboi M.

Clin Lung Cancer. 2019 Mar;20(2):e163-e170. doi: 10.1016/j.cllc.2018.11.001. Epub 2018 Nov 15.

PMID:
30559083
13.

Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.

Sakai T, Aokage K, Neri S, Nakamura H, Nomura S, Tane K, Miyoshi T, Sugano M, Kojima M, Fujii S, Kuwata T, Ochiai A, Iyoda A, Tsuboi M, Ishii G.

Lung Cancer. 2018 Dec;126:64-71. doi: 10.1016/j.lungcan.2018.10.021. Epub 2018 Oct 28.

PMID:
30527194
14.

Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis.

Udagawa H, Umemura S, Murakami I, Mimaki S, Makinoshima H, Ishii G, Miyoshi T, Kirita K, Matsumoto S, Yoh K, Niho S, Tsuchihara K, Goto K.

Lung Cancer. 2018 Dec;126:182-188. doi: 10.1016/j.lungcan.2018.11.014. Epub 2018 Nov 12.

PMID:
30527185
15.

Characterization of the tumor immune-microenvironment of lung adenocarcinoma associated with usual interstitial pneumonia.

Ueda T, Aokage K, Mimaki S, Tane K, Miyoshi T, Sugano M, Kojima M, Fujii S, Kuwata T, Ochiai A, Kusumoto M, Suzuki K, Tsuchihara K, Nishikawa H, Goto K, Tsuboi M, Ishii G.

Lung Cancer. 2018 Dec;126:162-169. doi: 10.1016/j.lungcan.2018.11.006. Epub 2018 Nov 6.

PMID:
30527182
16.

Survival and prognostic factors after pulmonary metastasectomy of head and neck cancer: what are the clinically informative prognostic indicators?

Oki T, Hishida T, Yoshida J, Goto M, Sekihara K, Miyoshi T, Aokage K, Ishii G, Tsuboi M.

Eur J Cardiothorac Surg. 2019 May 1;55(5):942-947. doi: 10.1093/ejcts/ezy384.

PMID:
30476033
17.

Spatiotemporal characteristics of fibroblasts-dependent cancer cell invasion.

Miyashita T, Omori T, Nakamura H, Sugano M, Neri S, Fujii S, Hashimoto H, Tsuboi M, Ochiai A, Ishii G.

J Cancer Res Clin Oncol. 2019 Feb;145(2):373-381. doi: 10.1007/s00432-018-2798-y. Epub 2018 Nov 23.

PMID:
30470886
18.

Clinical prediction of solitary pulmonary nodule after a curative resection for gastric cancer.

Kanai R, Tane K, Ishii G, Suzuki J, Sakai T, Okada S, Miyoshi T, Aokage K, Tsuboi M.

Jpn J Clin Oncol. 2018 Dec 1;48(12):1083-1087. doi: 10.1093/jjco/hyy146.

PMID:
30321372
19.

Differences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomas.

Katsumata S, Aokage K, Miyoshi T, Tane K, Nakamura H, Sugano M, Kojima M, Fujii S, Kuwata T, Ochiai A, Hayashi R, Tsuboi M, Ishii G.

J Thorac Cardiovasc Surg. 2018 Oct;156(4):1679-1688.e2. doi: 10.1016/j.jtcvs.2018.05.053. Epub 2018 Jun 4.

PMID:
30257286
20.

[A Case of Metachronous Cancer Originating from Five Different Organs].

Murakami M, Kimura T, Iwamoto M, Honda M, Ishii G, Koike Y, Sasaki H, Furuta A, Miki K, Ikegami M, Egawa S.

Hinyokika Kiyo. 2018 May;64(5):231-234. doi: 10.14989/ActaUrolJap_64_5_231. Japanese.

PMID:
30064163
21.

Collagen type I induces EGFR-TKI resistance in EGFR-mutated cancer cells by mTOR activation through Akt-independent pathway.

Yamazaki S, Higuchi Y, Ishibashi M, Hashimoto H, Yasunaga M, Matsumura Y, Tsuchihara K, Tsuboi M, Goto K, Ochiai A, Ishii G.

Cancer Sci. 2018 Jun;109(6):2063-2073. doi: 10.1111/cas.13624.

22.

Utility of Site-Specific Biopsy for Diagnosis of Desmoplastic Malignant Mesothelioma.

Sakai T, Tane K, Usui Y, Miyoshi T, Matsumoto S, Aokage K, Goto K, Suzuki M, Ishii G, Tsuboi M.

Ann Thorac Surg. 2018 Sep;106(3):e125-e128. doi: 10.1016/j.athoracsur.2018.02.062. Epub 2018 Mar 28.

PMID:
29601807
23.

Podoplanin: An emerging cancer biomarker and therapeutic target.

Krishnan H, Rayes J, Miyashita T, Ishii G, Retzbach EP, Sheehan SA, Takemoto A, Chang YW, Yoneda K, Asai J, Jensen L, Chalise L, Natsume A, Goldberg GS.

Cancer Sci. 2018 May;109(5):1292-1299. doi: 10.1111/cas.13580. Review.

24.

The ratio of cancer cells to stroma within the invasive area is a histologic prognostic parameter of lung adenocarcinoma.

Ichikawa T, Aokage K, Sugano M, Miyoshi T, Kojima M, Fujii S, Kuwata T, Ochiai A, Suzuki K, Tsuboi M, Ishii G.

Lung Cancer. 2018 Apr;118:30-35. doi: 10.1016/j.lungcan.2018.01.023. Epub 2018 Jan 31.

PMID:
29571999
25.

Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.

Nakasone S, Mimaki S, Ichikawa T, Aokage K, Miyoshi T, Sugano M, Kojima M, Fujii S, Kuwata T, Ochiai A, Tsuboi M, Goto K, Tsuchihara K, Ishii G.

J Cancer Res Clin Oncol. 2018 May;144(5):893-900. doi: 10.1007/s00432-018-2619-3. Epub 2018 Mar 6.

PMID:
29511884
26.

Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma.

Makinoshima H, Umemura S, Suzuki A, Nakanishi H, Maruyama A, Udagawa H, Mimaki S, Matsumoto S, Niho S, Ishii G, Tsuboi M, Ochiai A, Esumi H, Sasaki T, Goto K, Tsuchihara K.

Cancer Res. 2018 May 1;78(9):2179-2190. doi: 10.1158/0008-5472.CAN-17-2109. Epub 2018 Feb 28.

27.

Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung.

Ueda T, Aokage K, Nishikawa H, Neri S, Nakamura H, Sugano M, Tane K, Miyoshi T, Kojima M, Fujii S, Kuwata T, Ochiai A, Kusumoto M, Suzuki K, Tsuboi M, Ishii G.

J Cancer Res Clin Oncol. 2018 May;144(5):835-844. doi: 10.1007/s00432-018-2602-z. Epub 2018 Feb 12.

PMID:
29435735
28.

A secondary RET mutation in the activation loop conferring resistance to vandetanib.

Nakaoku T, Kohno T, Araki M, Niho S, Chauhan R, Knowles PP, Tsuchihara K, Matsumoto S, Shimada Y, Mimaki S, Ishii G, Ichikawa H, Nagatoishi S, Tsumoto K, Okuno Y, Yoh K, McDonald NQ, Goto K.

Nat Commun. 2018 Feb 12;9(1):625. doi: 10.1038/s41467-018-02994-7.

29.

Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.

Nakamura H, Ichikawa T, Nakasone S, Miyoshi T, Sugano M, Kojima M, Fujii S, Ochiai A, Kuwata T, Aokage K, Suzuki K, Tsuboi M, Ishii G.

Lung Cancer. 2018 Jan;115:56-63. doi: 10.1016/j.lungcan.2017.11.013. Epub 2017 Nov 20.

PMID:
29290263
30.

Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.

Aokage K, Miyoshi T, Ishii G, Kusumoto M, Nomura S, Katsumata S, Sekihara K, Tane K, Tsuboi M.

J Thorac Oncol. 2018 Apr;13(4):533-542. doi: 10.1016/j.jtho.2017.11.129. Epub 2017 Dec 13.

31.

Immunohistochemical and genetic characteristics of lung cancer mimicking organizing pneumonia.

Ichikawa T, Saruwatari K, Mimaki S, Sugano M, Aokage K, Kojima M, Hishida T, Fujii S, Yoshida J, Kuwata T, Ochiai A, Suzuki K, Tsuboi M, Goto K, Tsuchihara K, Ishii G.

Lung Cancer. 2017 Nov;113:134-139. doi: 10.1016/j.lungcan.2017.10.001. Epub 2017 Oct 5.

PMID:
29110840
32.

Clinical and Pathological Staging Validation in the Eighth Edition of the TNM Classification for Lung Cancer: Correlation between Solid Size on Thin-Section Computed Tomography and Invasive Size in Pathological Findings in the New T Classification.

Aokage K, Miyoshi T, Ishii G, Kusumoto M, Nomura S, Katsumata S, Sekihara K, Hishida T, Tsuboi M.

J Thorac Oncol. 2017 Sep;12(9):1403-1412. doi: 10.1016/j.jtho.2017.06.003. Epub 2017 Jun 13.

33.

CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors.

Ishibashi M, Neri S, Hashimoto H, Miyashita T, Yoshida T, Nakamura Y, Udagawa H, Kirita K, Matsumoto S, Umemura S, Yoh K, Niho S, Tsuboi M, Masutomi K, Goto K, Ochiai A, Ishii G.

Sci Rep. 2017 Apr 21;7:46662. doi: 10.1038/srep46662.

34.

A novel method to generate single-cell-derived cancer-associated fibroblast clones.

Hashimoto H, Suda Y, Miyashita T, Ochiai A, Tsuboi M, Masutomi K, Kiyono T, Ishii G.

J Cancer Res Clin Oncol. 2017 Aug;143(8):1409-1419. doi: 10.1007/s00432-017-2409-3. Epub 2017 Mar 31.

PMID:
28364361
35.

Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma.

Neri S, Miyashita T, Hashimoto H, Suda Y, Ishibashi M, Kii H, Watanabe H, Kuwata T, Tsuboi M, Goto K, Menju T, Sonobe M, Date H, Ochiai A, Ishii G.

Cancer Lett. 2017 Jun 1;395:20-30. doi: 10.1016/j.canlet.2017.02.026. Epub 2017 Mar 9.

PMID:
28286261
36.

Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in the Tumor Microenvironment After Radiotherapy.

Ishii G.

EBioMedicine. 2017 Mar;17:7-8. doi: 10.1016/j.ebiom.2017.03.004. Epub 2017 Mar 4. No abstract available.

37.

Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation.

Takeuchi S, Fukuda K, Yamada T, Arai S, Takagi S, Ishii G, Ochiai A, Iwakiri S, Itoi K, Uehara H, Nishihara H, Fujita N, Yano S.

Cancer Sci. 2017 Apr;108(4):696-703. doi: 10.1111/cas.13190. Epub 2017 Apr 12.

38.

Single cell time-lapse analysis reveals that podoplanin enhances cell survival and colony formation capacity of squamous cell carcinoma cells.

Miyashita T, Higuchi Y, Kojima M, Ochiai A, Ishii G.

Sci Rep. 2017 Jan 6;7:39971. doi: 10.1038/srep39971.

39.

Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial.

Yoh K, Seto T, Satouchi M, Nishio M, Yamamoto N, Murakami H, Nogami N, Matsumoto S, Kohno T, Tsuta K, Tsuchihara K, Ishii G, Nomura S, Sato A, Ohtsu A, Ohe Y, Goto K.

Lancet Respir Med. 2017 Jan;5(1):42-50. doi: 10.1016/S2213-2600(16)30322-8. Epub 2016 Nov 4.

PMID:
27825616
40.

Safety of fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: A prospective randomized clinical trial.

Hata K, Kimura T, Tsuzuki S, Ishii G, Kido M, Yamamoto T, Sasaki H, Miki J, Yamada H, Furuta A, Miki K, Egawa S.

Int J Urol. 2016 Nov;23(11):923-928. doi: 10.1111/iju.13189. Epub 2016 Aug 21.

41.

Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma.

Shimizu K, Kirita K, Aokage K, Kojima M, Hishida T, Kuwata T, Fujii S, Ochiai A, Funai K, Yoshida J, Tsuboi M, Ishii G.

J Cancer Res Clin Oncol. 2017 Feb;143(2):321-328. doi: 10.1007/s00432-016-2285-2. Epub 2016 Oct 22.

PMID:
27771795
42.

Changes in the tumor microenvironment during lymphatic metastasis of lung squamous cell carcinoma.

Ikemura S, Aramaki N, Fujii S, Kirita K, Umemura S, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Kuwata T, Kojima M, Ochiai A, Betsuyaku T, Tsuboi M, Goto K, Ishii G.

Cancer Sci. 2017 Jan;108(1):136-142. doi: 10.1111/cas.13110. Epub 2017 Jan 21.

43.

Thin-section computed tomography findings of lung adenocarcinoma with inherent metastatic potential.

Suzuki S, Aokage K, Yoshida J, Ishii G, Matsumura Y, Haruki T, Hishida T, Nagai K.

Surg Today. 2017 May;47(5):619-626. doi: 10.1007/s00595-016-1416-3. Epub 2016 Sep 22.

PMID:
27659289
44.

The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer.

Goto M, Naito M, Saruwatari K, Hisakane K, Kojima M, Fujii S, Kuwata T, Ochiai A, Nomura S, Aokage K, Hishida T, Yoshida J, Yokoi K, Tsuboi M, Ishii G.

J Cancer Res Clin Oncol. 2017 Feb;143(2):215-223. doi: 10.1007/s00432-016-2271-8. Epub 2016 Sep 17.

PMID:
27640003
45.

Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung.

Naito M, Aokage K, Saruwatari K, Hisakane K, Miyoshi T, Hishida T, Yoshida J, Masato S, Kojima M, Kuwata T, Fujii S, Ochiai A, Sato Y, Tsuboi M, Ishii G.

Lung Cancer. 2016 Oct;100:53-62. doi: 10.1016/j.lungcan.2016.07.024. Epub 2016 Jul 27.

PMID:
27597281
46.

Non-immune mediated thrombocytopenia caused by thromboprophylaxis for the perioperative care of urological surgery: A case report and review of the literature.

Hata K, Kimura T, Ishii G, Suzuki M, Egawa S.

Int J Surg Case Rep. 2016;27:21-23. doi: 10.1016/j.ijscr.2016.07.049. Epub 2016 Jul 30.

47.

Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung.

Miyoshi T, Umemura S, Matsumura Y, Mimaki S, Tada S, Makinoshima H, Ishii G, Udagawa H, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Aokage K, Hishida T, Yoshida J, Nagai K, Goto K, Tsuboi M, Tsuchihara K.

Clin Cancer Res. 2017 Feb 1;23(3):757-765. doi: 10.1158/1078-0432.CCR-16-0355. Epub 2016 Aug 9.

48.

Overexpression of microRNA-155 suppresses chemokine expression induced by Interleukin-13 in BEAS-2B human bronchial epithelial cells.

Matsukura S, Osakabe Y, Sekiguchi A, Inoue D, Kakiuchi Y, Funaki T, Yamazaki Y, Takayasu H, Tateno H, Kato E, Wakabayashi A, Hayashi M, Ishii G, Yamaguchi F, Tsuchiya Y, Kasahara K, Sagara H, Kokubu F.

Allergol Int. 2016 Sep;65 Suppl:S17-23. doi: 10.1016/j.alit.2016.04.018. Epub 2016 Aug 3.

49.

The novel one-step nucleic acid amplification (OSNA) assay for the diagnosis of lymph node metastasis in patients with non-small cell lung cancer (NSCLC): Results of a multicenter prospective study.

Nakagawa K, Asamura H, Tsuta K, Nagai K, Yamada E, Ishii G, Mitsudomi T, Ito A, Higashiyama M, Tomita Y, Inoue M, Morii E, Matsuura N, Okumura M.

Lung Cancer. 2016 Jul;97:1-7. doi: 10.1016/j.lungcan.2016.03.015. Epub 2016 Mar 28.

PMID:
27237020
50.

Meningitis-retention Syndrome; A Case Report.

Ishii G, Hata K, Aoki S, Suzuki M, Kimura T, Egawa S.

Urol Case Rep. 2016 Mar 21;6:42-4. doi: 10.1016/j.eucr.2016.02.010. eCollection 2016 May.

Supplemental Content

Support Center